Liraglutide
- Product NDC
- 72603-745
- 11-digit product format
- 726030745
- Labeler code
- 72603
- Product ID
- 72603-745_03ea668e-c7ca-40fd-ba05-3e9949a05325
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- liraglutide
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Labeler
- NorthStar Rx LLC
- Application
- ANDA218115
- Marketing category
- ANDA
- Marketing start
- 2026-03-01
- Substance
- LIRAGLUTIDE
- Active strength
- 6 mg/mL
- Pharmacologic classes
- GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Liraglutide
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LIRAGLUTIDE | 6 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 839I73S42A |
| Rxcui | 897122 |
DailyMed Product Concepts#
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 72603-745-02 | 72603074502 | 2 SYRINGE, PLASTIC in 1 CARTON (72603-745-02) / 3 mL in 1 SYRINGE, PLASTIC | 2026-03-01 | No | No | Current |
| 72603-745-03 | 72603074503 | 3 SYRINGE, PLASTIC in 1 CARTON (72603-745-03) / 3 mL in 1 SYRINGE, PLASTIC | 2026-03-01 | No | No | Current |